NWSA vs TXG · rev $9.03B vs rev $301.9M
NWSA (NWSA) versus 10X Genomics Inc (TXG) — a side-by-side from cached financials, not a winner call.
NWSA (NWSA) common stock.
10X Genomics Inc (TXG) is a health information services company listed on NASDAQ.
Latest reported NWSA revenue for 2026-06-30 was $9.03B. Net income was $573.0M. Revenue was up 328.1% from 2025-06-30 to 2026-06-30. NWSA currently screens at market cap $0.
Latest reported TXG revenue for 2026-06-30 was $301.9M. Net income was -$31.4M. TXG currently screens at market cap $4.08B.
NWSA currently screens at market cap $0. TXG currently screens at market cap $4.08B.
Not investment advice. Open the NWSA and TXG stock pages for the full models.
Not investment advice.